• Media
• News Releases
  • By Year
    • 2010
    • 2009
    • 2008
    • 2007
    • 2006
    • 2005
    • 2004
• Media Resources
  • Corporate
  • Central Nervous System Disorders
  • Cancer
  • Pain
• Featured Profiles
  • Healthcare Professionals
  • Programs
  • Products
• On The Record
  • Cephalon Response to JAMA Article “The Effects of Modafinil on Dopamine and Dopamine Transporters in the Male Human Brain”
  • Archive
    • Q&A on Settlements Regarding Investigations into Cephalon Business Practices
    • Our Commitment to Appropriate Interactions with Healthcare Professionals
    • Our Position on Tamper-Deterrent Formulation of Extended-Release Opioids
    • Set the Record Straight About ACTIQ®
    • Set the Record Straight About PROVIGIL®

Home > Media > Media Resources

Media Resources

This section is specifically for journalists who wish to learn about Cephalon and its eight proprietary products in the United States.

Downloadable press kits, fact sheets, prescribing information and other information about our products is available according to focus area: Central Nervous System Disorders, Cancer, and Pain.